Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does old age contraindicate TURP

J Balslev Jørgensen1, C Seidelin, F Petersen

  • 1Department of Urology H, Gentofte Hospital, University of Copenhagen, Denmark.

European Urology
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is associated with IRF7, BANK1 and TBX21 polymorphisms in two populations.

European journal of neurology·2020
Same author

The Regulatory Role of the Oral Commensal Streptococcus mitis on Human Monocytes.

Scandinavian journal of immunology·2017
Same author

The Value of Phrenic-Exairesis in the Treatment of Pulmonary Tuberculosis.

The Indian medical gazette·2017
Same author

A New and Simple Treatment for Intestinal Tuberculosis, Introduced by M. McConkey.

The Indian medical gazette·2017
Same author

An Investigation of After-Histories of Sanatorium Patients in India.

The Indian medical gazette·2017
Same author

An Indian Journal of Tuberculosis.

The Indian medical gazette·2017
Same journal

Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics.

European urology·2026
Same journal

Re: Twelve-month Results from the CISTO Study Comparing Radical Cystectomy Versus Bladder-sparing Therapy for Recurrent High-grade Non-muscle-invasive Bladder Cancer: Recurrent High-risk NMIBC: One Bladder, Choose Wisely.

European urology·2026
Same journal

Re: Dries Develtere, Riccardo Bertolo. Cumulative Genitourinary Toxicity After Prostate Radiotherapy: High-Level Long-Term Randomized Evidence. J Clin Oncol. Online ahead of print. http://dx.doi.org/10.1200/JCO-26-00436.

European urology·2026
Same journal

In Memory of Paul Mitrofanoff (1934-2025).

European urology·2026
Same journal

Re: McKay RR, Pal S, Xie W, et al. Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert Consensus on the Management of Renal Cell and Urinary Tract Cancers. CA Cancer J Clin 2026;76:e70052.

European urology·2026
Same journal

Re: Ultra-hypofractionated Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma: 5-year Outcomes from a Pooled Analysis of the FASTRACK Trials.

European urology·2026
See all related articles

Transurethral prostatic resection (TURP) can benefit elderly men over 80 years old. Careful patient selection is crucial for positive outcomes in treating lower urinary tract symptoms (LUTS).

Area of Science:

  • Geriatric Urology
  • Surgical Oncology
  • Urologic Oncology

Background:

  • Lower urinary tract symptoms (LUTS) significantly impact quality of life in elderly men.
  • Transurethral prostatic resection (TURP) is a common treatment for benign prostatic hyperplasia (BPH).
  • The safety and efficacy of TURP in very elderly patients (over 80) require further investigation.

Purpose of the Study:

  • To evaluate the prognostic role of advanced age on survival outcomes following TURP.
  • To assess the benefits and risks of TURP in men over 80 years old with LUTS.

Main Methods:

  • Retrospective study of men over 80 years old treated for LUTS.
  • Comparison of survival rates between patients who underwent TURP and those who did not (too ill for surgery or declined treatment).

Related Experiment Videos

  • Survival analysis compared to the age-matched general population.

    • Main Results:

    • A significantly higher initial mortality was observed in the TURP group compared to the background population.
    • Twelve patients (4.8%) died within 30 days post-operation, primarily those with severe preoperative comorbidity.
    • Most patients (97/249) experienced resolution of chronic retention, with only 17 requiring a catheter at discharge.

    Conclusions:

    • TURP offers significant survival benefits for carefully selected elderly men (over 80) with LUTS.
    • Patient selection, considering preoperative comorbidity, is paramount for successful TURP outcomes in this age group.
    • TURP can be a safe and effective treatment option for very old men when indications are appropriate.